31
Participants
Start Date
November 30, 2005
Primary Completion Date
November 30, 2007
Study Completion Date
February 29, 2008
bevacizumab
Hamid Ahmadieh, MD, Tehran
Shahid Beheshti University of Medical Sciences
OTHER